FDA.gov Archives - World Asthma Foundation

March 23, 2016

FDA approves Cinqair to treat severe asthma – FDA.gov

FDA approves Cinqair to treat severe asthma
FDA.gov
The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older. Cinqair is approved for patients who have a history of …
Reslizumab (Cinqair) Approved to Treat Severe AsthmaMedscape
FDA Approves Reslizumab for Adults With Severe AsthmaMedPage Today
FDA clears Teva's asthma med CinqairSeeking Alpha
Monthly Prescribing Reference (registration)
all 25 news articles »

View full post on asthma – Google News

November 4, 2015

FDA approves Nucala to treat severe asthma – FDA.gov

FDA approves Nucala to treat severe asthma
FDA.gov
The U.S. Food and Drug Administration today approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment of asthma in patients age 12 years and older. Nucala is approved for patients who have a history of severe …
FDA Approves New Asthma MedicationMedPage Today

all 2 news articles »

View full post on asthma – Google News

June 11, 2012

Children and Asthma: The Goal Is Control – FDA.gov

FDA.gov

Children and Asthma: The Goal Is Control
FDA.gov
The news about children and asthma is both good and bad. Better treatments have banished the stereotype of the asthmatic child as frail and inactive, heavily relying on an inhaler to breathe. Children with asthma are now living active, …

View full post on asthma – Google News